✦ LIBER ✦

Treatment of acute myeloid leukemia in the elderly with low-dose cytarabine, hydroxyurea, and calcitriol

✍ Scribed by Christopher A. Slapak; Jane F. Desforges; Terry Fogaren; Dr. Kenneth B. Miller

Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 571 KB
Volume: 41
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.2830410307

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Arsenic trioxide and low-dose cytarabine

Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia

✍ Gail J. Roboz; Ellen K. Ritchie; Tania Curcio; Juliette Provenzano; Rebecca Carl 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

## Abstract ## BACKGROUND. Acute myeloid leukemia (AML) carries a dismal prognosis in older patients. In this study, the authors evaluated the safety and efficacy of arsenic trioxide combined with low‐dose cytarabine in untreated patients aged ≥60 years with AML. ## METHODS. In a phase 1/2 desig

Intensive induction chemotherapy with re

Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia

✍ Jiazhuo Liu; Yingchang Mi; Mingwei Fu; Wenjuan Yu; Ying Wang; Dong Lin; Shougeng 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB 👁 2 views

Salvage therapy with endostatin, low-dos

Salvage therapy with endostatin, low-dose homoharringtonine, and cytarabine in combination with granulocyte-colony stimulating factor for elderly patients with primary refractory acute myeloid leukemia

✍ Baijun Fang; Yuzhang Liu; Jian Zhou; Yanan Li; Yongping Song 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 850 KB

Treatment of acute myeloid leukemia in t

Treatment of acute myeloid leukemia in the elderly: A clinical dilemma

✍ Dr. J. A. Copplestone; A. G. Smith; C. Osmond; D. G. Oscier; T. J. Hamblin 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 530 KB

Fifty-four patients representing all the cases of acute myeloid leukemia in patients aged over 60 years, presenting to three adjacent hospitals, were studied. Only 26 of the 54 patients were considered suitable for remission induction with intensive combination chemotherapy which produced seven comp

A comparison of low-dose cytarabine and

A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment

✍ Alan K. Burnett; Donald Milligan; Archie G. Prentice; Anthony H. Goldstone; Mary 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

Combination chemotherapy with low-dose c

Combination chemotherapy with low-dose cytarabine, homoharringtonine, and granulocyte colony-stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia

✍ Wang-Gang Zhang; Fang-Xia Wang; Yin-Xia Chen; Xin-Mei Cao; Ai-Li He; Jie Liu; Xi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 2 views

## Abstract As sensitization of leukemic cells with granulocyte colony‐stimulating factor (G‐csf) can enhance the cytotoxicity of chemotherapy in acute myeloid leukemia (AML), a pilot study was conducted in order to evaluate the effect of G‐csf priming combined with low‐dose chemotherapy in patient